These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 522608)
1. Increased amphetamine potency following chronic naltrexone administration in rats. Amir S; Blair R; Amit Z Life Sci; 1979 Oct; 25(16):1407-12. PubMed ID: 522608 [No Abstract] [Full Text] [Related]
2. Some central effects of opioid antagonists. Part I. Skorupska M; LangwiĆski R Pol J Pharmacol Pharm; 1989; 41(5):401-11. PubMed ID: 2577060 [TBL] [Abstract][Full Text] [Related]
3. Potentiation by naltrexone of d-amphetamine-induced behavioral suppression and its reversal by clonidine. Fossom LH; Sparber SB Life Sci; 1982 Dec; 31(25):2827-35. PubMed ID: 7162354 [No Abstract] [Full Text] [Related]
4. Effects of chronic naltrexone on amphetamine locomotor activity. Ng Cheong Ton MJ; Blair R; Holmes L; Amit Z Subst Alcohol Actions Misuse; 1983; 4(4):331-6. PubMed ID: 6322365 [TBL] [Abstract][Full Text] [Related]
5. Potentiation of apomorphine and D-amphetamine effects by naloxone. Adams PM; Beauchamp R; Alston C Life Sci; 1981 Feb; 28(6):629-34. PubMed ID: 7193793 [No Abstract] [Full Text] [Related]
6. Analeptic and antianaleptic effects of naloxone and naltrexone in rabbits. Horita A; Carino MA Life Sci; 1978 Oct; 23(16):1681-6. PubMed ID: 31527 [No Abstract] [Full Text] [Related]
7. Effect of naloxone and naltrexone on the development of satiation measured in the runway: comparisons with d-amphetamine and d-fenfluramine. Kirkham TC; Blundell JE Pharmacol Biochem Behav; 1986 Jul; 25(1):123-8. PubMed ID: 3749218 [TBL] [Abstract][Full Text] [Related]
8. Naltrexone antagonism of exploration in the rat. Katz RJ Int J Neurosci; 1979; 9(1):49-51. PubMed ID: 437945 [No Abstract] [Full Text] [Related]
9. Inhibitory effects of amphetamine, L-DOPA and apomorphine on morphine-induced behavioural excitation of rats. Ayhan IH; Randrup A Arch Int Pharmacodyn Ther; 1973 Aug; 204(2):283-92. PubMed ID: 4748782 [No Abstract] [Full Text] [Related]
10. ACTH1-39 but not naltrexone produces biphasic effects on locomotor activity. Blair R; Galina ZH; Sutherland C; Amit Z Peptides; 1983; 4(1):117-20. PubMed ID: 6306614 [TBL] [Abstract][Full Text] [Related]
12. Serotonergic influence on the potentiation of D-amphetamine and apomorphine-induced rotational behavior by the alpha2-adrenoceptor antagonist 2-methoxy idazoxan in hemiparkinsonian rats. Srinivasan J; Schmidt WJ J Neural Transm (Vienna); 2005 Sep; 112(9):1223-36. PubMed ID: 15614426 [TBL] [Abstract][Full Text] [Related]
13. Acute effects of naloxone and naltrexone, but lack of delayed effects, on exploratory behavior in the rat. Koek W; Slangen JL Psychopharmacology (Berl); 1984; 84(3):383-7. PubMed ID: 6440184 [TBL] [Abstract][Full Text] [Related]
14. Multi-dimensional analyses of behavior in mice treated with naltrexone. Ukai M; Kameyama T Physiol Behav; 1985 Feb; 34(2):311-3. PubMed ID: 2987990 [TBL] [Abstract][Full Text] [Related]
15. The behavioural effects of (+)-amphetamine and apomorphine in the marmoset [proceedings]. Ridley RM; Crow TJ Br J Pharmacol; 1978 Mar; 62(3):393P. PubMed ID: 416868 [No Abstract] [Full Text] [Related]
16. Detailed analysis of the effects of apomorphine and d-amphetamine on spontaneous locomotor behaviour of rats as measured in a TV-based, automated open-field system. Nickolson VJ Eur J Pharmacol; 1981 Jun; 72(1):45-56. PubMed ID: 7262194 [TBL] [Abstract][Full Text] [Related]